The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis
Abstract
Objective Insulin resistance and nonalcoholic fatty liver disease have been linked to several lipid metabolites in animals, but their role in humans remains unclear. This study examined the relationship of sphingolipids with hepatic and peripheral metabolism in 21 insulin-resistant obese patients without (NAFL-) or with (NAFL+) nonalcoholic fatty liver and nonalcoholic steatohepatitis (NASH) and 7 healthy lean individuals undergoing tissue biopsies during bariatric or elective abdominal surgery. Research design and methods Hyperinsulinemic-euglycemic clamps with d-[6,6- 2 H 2 ]glucose were performed to quantify tissue-specific insulin sensitivity. Hepatic oxidative capacity, lipid peroxidation, and the phosphorylated-to-total c-Jun N-terminal kinase (pJNK-to-tJNK) ratio were measured to assess mitochondrial function, oxidative stress, and inflammatory activity. Results Hepatic total ceramides were higher by 50% and 33% in NASH compared with NAFL+ and NAFL-, respectively. Only in NASH were hepatic dihydroceramides (16:0, 22:0, and 24:1) and lactosylceramides increased. Serum total ceramides and dihydroceramides (hepatic dihydroceramides 22:0 and 24:1) correlated negatively with whole-body but not with hepatic insulin sensitivity. Hepatic maximal respiration related positively to serum lactosylceramide subspecies, hepatic sphinganine, and lactosylceramide 14:0. Liver lipid peroxides (total ceramides, sphingomyelin 22:0) and the pJNK-to-tJNK ratio (ceramide 24:0; hexosylceramide…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“With increasing hepatic lipid accumulation, the generation of toxic lipid intermediates (diacylglycerols, ceramides) and altered hepatic mitochondrial respiration rates drive hepatic insulin resistance, inflammation and oxidative stress -all of them fueling pro-fibrotic pathways (Fig. 1) [26,27].”
From Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease? (2024) · cites this paper as [27]
In the citing paper
“Patients with MASH have 20% higher ceramide concentrations compared to healthy individuals.100,102,104,117”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [100]
In the citing paper
“High levels of plasma ceramides are correlated with the severity of MASLD and reflect hepatic ceramide accumulation.”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [100]
In the citing paper
“Ceramides are among the most studied lipids because of their lipotoxic activity in several organs and have been reported to be increased in the plasma of patients with MASLD.94,[99], [100], [101], [102],[107], [108], [109],115”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [100]
In the citing paper
“Among ceramides, in a small cohort of seven patients, Apostolopoulou et al.100 showed that total ceramides, as well as lactosyl-, hexosyl-, and dihydro-ceramides were significantly increased in MASH”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [100]
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Sphingolipid metabolites in inflammatory disease
Maceyka, M., & Spiegel, S. (2014) · Nature · doi:10.1038/nature13475 · Cited by 1,277 · cited 3×
“HDL-cholesterol (mg/dL) 64 (57, 83)¶,# 44 (35, 54) 35 (33,45) 52 (43, 59)”
BackgroundKoliaki, C., Szendroedi, J., Kaul, K., Jelenik, T., Nowotny, P., Jankowiak, F., Herder, C., Carstensen, M., Krausch, M., Knoefel, W. T., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.004 · Cited by 1,032
Self-citationTilg, H., Moschen, A. R., & Roden, M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.147 · Cited by 1,002 · cited 8×
“The NAFL+ group included one participant with T2D.”
BackgroundMethodInfluentialSelf-citationReceptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
Holland, W. L., Miller, R. A., Wang, Z. V., Sun, K., Barth, B. M., Bui, H. H., Davis, K. E., Bikman, B. T., Halberg, N., Rutkowski, J. M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2277 · Cited by 892 · cited 1×
“Rodent studies using a high-fat diet or in leptin-deficientob/obmicehave shown controversial resultsfortherelationshipof hepatic accumulation of ceramides with hepatic insulin sensitivity (26,27).”
BackgroundSelf-citationSunny, N. E., Parks, E. J., Browning, J. D., & Burgess, S. C. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.11.004 · Cited by 672 · cited 2×
“Of note, obese people have increased hepatic mitochondrial capacity (10,11), which declines in nonalcoholicsteatohepatitis (NASH)along”
BackgroundHaus, J. M., Kashyap, S. R., Kasumov, T., Zhang, R., Kelly, K. R., DeFronzo, R. A., & Kirwan, J. P. (2009) · Diabetes · doi:10.2337/db08-1228 · Cited by 663
Ceramides – Lipotoxic Inducers of Metabolic Disorders
Chaurasia, B., & Summers, S. A. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.07.006 · Cited by 616
The role of mitochondria in insulin resistance and type 2 diabetes mellitus
Szendroedi, J., Phielix, E., & Roden, M. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.138 · Cited by 600
Self-citationCellular mechanism of insulin resistance in nonalcoholic fatty liver disease
Kumashiro, N., Erion, D. M., Zhang, D., Kahn, M., Beddow, S. A., Chu, X., Still, C. D., Gerhard, G. S., Han, X., Dziura, J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113359108 · Cited by 585 · cited 1×
“Liver total ceramides did not relate to whole-body insulin sensitivity, extending previous findings using HOMA-insulin resistanceasasurrogateof insulinresistance (5).”
BackgroundAn FGF21-Adiponectin-Ceramide Axis Controls Energy Expenditure and Insulin Action in Mice
Holland, W. L., Adams, A. C., Brozinick, J. T., Bui, H. H., Miyauchi, Y., Kusminski, C. M., Bauer, S. M., Wade, M., Singhal, E., Cheng, C. C., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.03.019 · Cited by 535
Self-citationSeki, S., Kitada, T., Yamada, T., Sakaguchi, H., Nakatani, K., & Wakasa, K. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00073-9 · Cited by 521 · cited 1×
“with increased hepatic production of reactive oxygen species and oxidative DNA damage (10,12,13).”
BackgroundLuukkonen, P. K., Zhou, Y., Sädevirta, S., Leivonen, M., Arola, J., Orešič, M., Hyötyläinen, T., & Yki-Järvinen, H. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.002 · Cited by 461 · cited 2×
“resistant patients, underlining the role of de novo ceramide synthesis in human NAFLD (8).”
BackgroundHistopathology of nonalcoholic fatty liver disease
Brunt, E. M. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i42.5286 · Cited by 449 · cited 3×
“Alanine aminotransferase (units/L) 25 (19, 34) 25 (14, 25) 22 (17, 25) 32 (28, 40)”
BackgroundRole of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans
Szendroedi, J., Yoshimura, T., Phielix, E., Koliaki, C., Marcucci, M., Zhang, D., Jelenik, T., Müller, J., Herder, C., Nowotny, P., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409229111 · Cited by 415 · cited 1×
“diacylglycerol, but not ceramide, species predict the onset of insulin resistance (3).”
BackgroundSelf-citationUssher, J. R., Koves, T. R., Cadete, V. J. J., Zhang, L., Jaswal, J. S., Swyrd, S. J., Lopaschuk, D. G., Proctor, S. D., Keung, W., Muoio, D. M., et al. (2010) · Diabetes · doi:10.2337/db09-1293 · Cited by 362
Kotronen, A., Seppänen-Laakso, T., Westerbacka, J., Kiviluoto, T., Arola, J., Ruskeepää, A.-L., Orešič, M., & Yki-Järvinen, H. (2009) · Diabetes · doi:10.2337/db08-1074 · Cited by 245 · cited 1×
“In the human liver, some studies reported a negative relationship between hepatic total diacylglycerols, but not ceramides, and insulin sensitivity (4–6) and an elevation of hepatic diacylglycerol concentrations in patients with NAFLD (7).”
BackgroundIntrahepatic Diacylglycerol Content Is Associated With Hepatic Insulin Resistance in Obese Subjects
Magkos, F., Su, X., Bradley, D., Fabbrini, E., Conte, C., Eagon, J. C., Varela, J. E., Brunt, E. M., Patterson, B. W., & Klein, S. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.03.003 · Cited by 224 · cited 2×
“NAFLD activity score 0 (0, 2)##,*** 0 (0, 1)‡‡,§§§ 2 (2, 4)†† 5 (4, 6)”
BackgroundPlasma Dihydroceramides Are Diabetes Susceptibility Biomarker Candidates in Mice and Humans
Wigger, L., Cruciani-Guglielmacci, C., Nicolas, A., Denom, J., Fernandez, N., Fumeron, F., Marques-Vidal, P., Ktorza, A., Kramer, W., Schulte, A., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.019 · Cited by 218 · cited 2×
“ceramide species, particularly dihydroceramide18:0, as biomarkers of diabetes onset in mice and humans (16).”
BackgroundAbnormal Hepatic Energy Homeostasis in Type 2 Diabetes†
Szendroedi, J., Chmelik, M., Schmid, A. I., Nowotny, P., Brehm, A., Krssak, M., Moser, E., & Roden, M. (2009) · Hepatology · doi:10.1002/hep.23093 · Cited by 204 · cited 7×
“In the current study, hepatic ceramidespeciesdidnotcorrelate with basal EGP, whereas hepatic sphingosine related negatively with hepatic insulin sensitivity.”
BackgroundMethodInfluentialSelf-citationGarcía‐Ruiz, C., Colell, A., París, R., & Fernández‐Checa, J. C. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.847 · Cited by 197
Mitochondrial ROS production under cellular stress: comparison of different detection methods
Kuznetsov, A. V., Kehrer, I., Kozlov, A. V., Haller, M., Redl, H., Hermann, M., Grimm, M., & Troppmair, J. (2011) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-011-4764-2 · Cited by 188
de Mello, V. D. F., Lankinen, M., Schwab, U., Kolehmainen, M., Lehto, S., Seppänen-Laakso, T., Orešič, M., Pulkkinen, L., Uusitupa, M., & Erkkilä, A. T. (2009) · Diabetologia · doi:10.1007/s00125-009-1482-9 · Cited by 181
Cohort profile: the German Diabetes Study (GDS)
The GDS Group, Szendroedi, J., Saxena, A., Weber, K. S., Straßburger, K., Herder, C., Burkart, V., Nowotny, B., Icks, A., Kuß, O., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0374-9 · Cited by 166
Self-citationter Horst, K. W., Gilijamse, P. W., Versteeg, R. I., Ackermans, M. T., Nederveen, A. J., la Fleur, S. E., Romijn, J. A., Nieuwdorp, M., Zhang, D., Samuel, V. T., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.035 · Cited by 162
Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity
Patterson, R. E., Kalavalapalli, S., Williams, C. M., Nautiyal, M., Mathew, J. T., Martinez, J., Reinhard, M. K., McDougall, D. J., Rocca, J. R., Yost, R. A., et al. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00492.2015 · Cited by 161
Pioglitazone in the treatment of NASH: the role of adiponectin
Gastaldelli, A., Harrison, S. A., Belfort‐Aguiar, R., Hardies, J., Balas, B., Schenker, S., & Cusi, K. J. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04405.x · Cited by 115
Association of Subclinical Inflammation With Polyneuropathy in the Older Population
Herder, C., Bongaerts, B. W. C., Rathmann, W., Heier, M., Kowall, B., Köenig, W., Thorand, B., Roden, M., Meisinger, C., & Ziegler, D. (2013) · Diabetes Care · doi:10.2337/dc13-0382 · Cited by 94 · cited 2×
“Interleukin6(IL-6), tumornecrosis factor-a (TNF-a) and IL-1 receptor antagonist (IL1RA)were quantified usingQuantikineHS (IL-6, TNF-a) or Quantikine (IL-1RA) ELISA kits (R&D Systems,Wiesbaden, Germany) (23).”
MethodSelf-citationGórnicka, A., Morris‐Stiff, G. J., Thapaliya, S., Papouchado, B. G., Berk, M. P., & Feldstein, A. E. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3815 · Cited by 76 · cited 1×
“with increased hepatic production of reactive oxygen species and oxidative DNA damage (10,12,13).”
BackgroundLactosylceramide contributes to mitochondrial dysfunction in diabetes
Novgorodov, S. A., Riley, C. L., Yu, J., Keffler, J. A., Clarke, C. J., Laer, A. O. V., Baicu, C. F., Zile, M. R., & Gudz, T. I. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m060061 · Cited by 68
Jeleník, T., Séquaris, G., Kaul, K., Ouwens, D. M., Phielix, E., Kotzka, J., Knebel, B., Weiß, J., Reinbeck, A. L., Janke, L., et al. (2014) · Diabetes · doi:10.2337/db13-1794 · Cited by 61
Self-citationThe adipokine/ceramide axis: Key aspects of insulin sensitization
Xia, J. Y., Morley, T. S., & Scherer, P. E. (2013) · Biochimie · doi:10.1016/j.biochi.2013.08.013 · Cited by 59 · cited 2×
“toplaya central role inNASHby improving liver histology in response to pioglitazone treatment (33) and to be associated with reduced tissue ceramides (29,30).”
BackgroundSelf-citationEffect of pioglitazone on plasma ceramides in adults with metabolic syndrome
Warshauer, J. T., Lopez, X., Gordillo, R., Hicks, J., Holland, W. L., Anuwe, E., Blankfard, M. B., Scherer, P. E., & Lingvay, I. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2662 · Cited by 51
Self-citationLiver Perilipin 5 Expression Worsens Hepatosteatosis But Not Insulin Resistance in High Fat-Fed Mice
Trevino, M. B., Mazur-Hart, D. J., Machida, Y., King, T., Nadler, J., Galkina, E., Poddar, A., Dutta, S. M., & Imai, Y. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1069 · Cited by 47 · cited 2×
“Rodent studies using a high-fat diet or in leptin-deficientob/obmicehave shown controversial resultsfortherelationshipof hepatic accumulation of ceramides with hepatic insulin sensitivity (26,27).”
Backgroundfor the GDS group, Apostolopoulou, M., Straßburger, K., Herder, C., Knebel, B., Kotzka, J., Szendroedi, J., & Roden, M. (2016) · Diabetologia · doi:10.1007/s00125-016-4038-9 · Cited by 29 · cited 3×
“Alanine aminotransferase (units/L) 25 (19, 34) 25 (14, 25) 22 (17, 25) 32 (28, 40)”
BackgroundSelf-citationEffects of sphingolipid synthesis inhibition on cholesterol gallstone formation in C57BL/6J mice
Lee, B. J., Kim, J. J., Kim, B. K., Jung, S. J., Joo, M. K., Hong, S. G., Kim, J. S., Kim, J. H., Yeon, J. E., Park, J., et al. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06246.x · Cited by 15 · cited 1×
“However, although increased ceramide concentrations in serumand inbilehavebeenreported inmice fed a lithogenic diet (37), whether cholecystectomy affects sphingolipid metabolism in healthy, lean humans is unknown.”
BackgroundReceptors grease the metabolic wheels
Holland, W. L., & Scherer, P. E. (2017) · Nature · doi:10.1038/nature21900 · Cited by 12 · cited 2×
“Alanine aminotransferase (units/L) 25 (19, 34) 25 (14, 25) 22 (17, 25) 32 (28, 40)”
BackgroundSelf-citation
Cited by
The integrative biology of type 2 diabetes
Roden, M., & Shulman, G. I. (2019) · Nature · doi:10.1038/s41586-019-1797-8 · Cited by 1,167
Self-citationWhy does obesity cause diabetes?
Klein, S., Gastaldelli, A., Yki-Järvinen, H., & Scherer, P. E. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2021.12.012 · Cited by 939
Self-citationThe complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments
Targher, G., Corey, K. E., Byrne, C. D., & Roden, M. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00448-y · Cited by 850
Self-citationTanase, D. M., Gosav, E. M., Costea, C. F., Ciocoiu, M., Lacatusu, C. M., Maranduca, M. A., Ouatu, A., & Floria, M. (2020) · Journal of Diabetes Research · doi:10.1155/2020/3920196 · Cited by 627
“Deletion of SREBP-1a promotes toll-like receptor-4 (TLR4) stimulation, increased inflammatory gene expression via reprogramming the fatty acid production [47], systemic IR, and reduction of the glucose transport [48].”
BackgroundThe Liver as an Endocrine Organ—Linking NAFLD and Insulin Resistance
Watt, M. J., Miotto, P. M., De Nardo, W., & Montgomery, M. K. (2019) · Endocrine Reviews · doi:10.1210/er.2019-00034 · Cited by 615
Metadata
- Authors
- Apostolopoulou, M., Gordillo, R., Koliaki, C., Gancheva, S., Jelenik, T., De Filippo, E., Herder, C., Markgraf, D., Jankowiak, F., Esposito, I., Schlensak, M., Scherer, P. E., & Roden, M.
- Affiliations
- Deutsches Diabetes-Zentrum e.V. (DE)
- The University of Texas Southwestern Medical Center (US)
- Division of Endocrinology and Diabetology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany
- Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine University, Düsseldorf, Germany
- Heinrich Heine University Düsseldorf (DE)
- Institute of Pathology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany
- Corresponding author
- Roden, Michael
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2018-03-30
- Volume
- 41
- Issue
- 6
- Pages
- 1235-1243
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2794512033
- Cited by
- 284
- References
- 37
- Citations by year
- 2026: 17 · 2025: 20 · 2024: 41 · 2023: 33 · 2022: 46 · 2021: 35 · 2020: 50 · 2019: 31 · 2018: 10
- FWCI
- 24.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Science and Research of the State of North Rhine-Westfalia
- German Federal Ministry of Health
- Federal Ministry for Research (BMBF) to the German Center for Diabetes Research
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, sphingolipids, ceramide, dihydroceramide, lactosylceramide, sphinganine, sphingomyelin, insulin resistance, hepatic insulin sensitivity, oxidative stress, lipid peroxidation, c-Jun N-terminal kinase, inflammation, mitochondrial function, obesity
- MeSH terms
- Adult, Animals, Female, Humans, Inflammation, Insulin Resistance, Liver, Male, Middle Aged, Obesity, Oxidation-Reduction, Prospective Studies, Sphingolipids, Lipid Peroxidation, Glucose Clamp Technique, Oxidative Stress, Disease Progression, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.